LPAAT-Theta Polyclonal Antibody

GPAT3 (glycerol-3-phosphate acyltransferase 3) encodes a member of the lysophosphatidic acid acyltransferase protein family. The encoded protein is an enzyme which catalyzes the conversion of glycerol-3-phosphate to lysophosphatidic acid in the synthesis of triacylglycerol. Multiple alternatively spliced variants, encoding the same protein, have been identified.

The LPAAT-Theta Polyclonal Antibody is a highly specific and sensitive antibody designed for the detection of Lysophosphatidic Acid Acyltransferase Theta (LPAAT-Theta) protein. This antibody is produced using high-quality polyclonal antibodies that have been purified and validated for use in various applications, including Western blotting, immunohistochemistry, and immunofluorescence.

The LPAAT-Theta Polyclonal Antibody is a reliable tool for researchers studying the role of LPAAT-Theta in various biological processes, including lipid metabolism, cell signaling, and cancer progression. This antibody has been extensively tested and validated for its specificity and sensitivity, ensuring accurate and reproducible results.

The LPAAT-Theta Polyclonal Antibody is available in various sizes and formats to meet the needs of different research applications. It is supplied in a convenient liquid form, making it easy to use and store. This antibody is also compatible with a wide range of secondary antibodies, allowing for flexible and customizable experimental designs.

Overall, the LPAAT-Theta Polyclonal Antibody is a high-quality research tool that provides reliable and accurate detection of LPAAT-Theta protein. Its specificity, sensitivity, and versatility make it an essential tool for researchers studying the role of LPAAT-Theta in various biological processes.